Adrian Krainer (scientist)
Adrian Krainer is a prominent scientist known for his significant contributions to the field of molecular biology and genetics. He is particularly renowned for his work on RNA splicing and the development of antisense oligonucleotide therapies.
Early Life and Education[edit | edit source]
Adrian Krainer was born in Buenos Aires, Argentina. He pursued his undergraduate studies at the University of Buenos Aires before moving to the United States for his graduate education. Krainer earned his Ph.D. in biochemistry from Harvard University under the mentorship of Tom Maniatis.
Career[edit | edit source]
Krainer began his career as a postdoctoral fellow at Cold Spring Harbor Laboratory (CSHL), where he later became a faculty member. His research at CSHL has focused on the mechanisms of pre-mRNA splicing and the role of splicing factors in genetic diseases.
Research Contributions[edit | edit source]
Krainer's work has been instrumental in understanding the process of RNA splicing, a critical step in the expression of genes. He has identified several key splicing factors and elucidated their roles in the splicing process. His research has also led to the development of therapeutic strategies for diseases caused by splicing defects.
One of Krainer's most notable achievements is the development of nusinersen (marketed as Spinraza), the first approved treatment for spinal muscular atrophy (SMA). This groundbreaking therapy uses antisense oligonucleotides to modulate splicing and increase the production of functional SMN protein in patients with SMA.
Awards and Honors[edit | edit source]
Adrian Krainer has received numerous awards and honors for his contributions to science, including:
- The Breakthrough Prize in Life Sciences
- The Wolf Prize in Medicine
- The RNA Society Lifetime Achievement Award
Personal Life[edit | edit source]
Krainer resides in New York with his family. He continues to conduct research and mentor young scientists at Cold Spring Harbor Laboratory.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD